When you think of lab animals, alpacas don’t usually spring to mind. But Geisel’s Mark Spaller and his students have started to focus on this small South American cousin of the camel as an important part of their antibody protein studies.
An excerpt from the book The Truth in Small Doses discusses the research of Michael Sporn, a Geisel professor of pharmacology and toxicology, who has long advocated for an unorthodox approach to battling cancer.
New Dartmouth study suggests removing the TV from a child’s bedroom could help prevent excessive weight gain.
Dartmouth’s Institute for Quantitative Biomedical Sciences (iQBS), a program established to advance and support interdisciplinary education and research at Dartmouth College, has reached a major milestone in infrastructure development.
Telemedicine used at nursing homes during hours when doctors are not typically present is a viable way to reduce avoidable hospitalizations, according to research published in February’s issue of Health Affairs.
Health apps for smartphones are nothing new. Now, health-care providers are increasingly using sophisticated technology-based medical applications to help patients manage chronic illnesses.
Lebanon, NH—Dartmouth researchers developed a new biological pathway-based computational model, called the Pathway-based Human Phenotype Network (PHPN), to identify underlying genetic connections between different diseases as reported in BioDataMining; this week. The PHPN mines the data present in large publicly available disease datasets to find shared SNPs, genes, or pathways and […]
Dartmouth engineers and radiologists are developing new approaches for an emerging technique in diagnostic imaging for breast cancer—MRI with near-infrared spectroscopy (NIRS).
A scientific breakthrough may give the field of radiation oncology new tools to increase the precision and safety of radiation treatment in cancer patients by helping doctors “see” the powerful beams of a linear accelerator as they enter or exit the body.
A new statistical approach to measuring the cancer burden in the United States reveals decades of progress in fighting cancer, progress previously masked by the falling death rates of other diseases.